Gland Pharma Limited (NSE:GLAND)
India · Delayed Price · Currency is INR 2,292.40
+42.40 (1.88%)
Jun 1, 2026, 3:30 PM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 370.7 billion as of June 1, 2026. Its market cap has increased by 57.78% in one year.
Market Cap
370.70B
Enterprise Value
339.21B
Revenue
64.31B
Ranking
n/a
PE Ratio
36.13
Stock Price
2,292.40
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has increased from 297.10B to 370.70B, an increase of 24.77%. That is a compound annual growth rate of 4.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 370.70B | 30.66% |
| Dec 31, 2025 | 283.71B | -3.22% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurobindo Pharma | 828.46B |
| Laurus Labs | 735.28B |
| Alkem Laboratories | 657.37B |
| Glenmark Pharmaceuticals | 641.98B |
| Ipca Laboratories | 386.75B |
| Ajanta Pharma | 365.78B |
| Wockhardt | 330.09B |
| Emcure Pharmaceuticals | 321.54B |